Royalty Report: Medical, Device, Surgical – Collection: 6931

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 9

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 9

Primary Industries

  • Medical
  • Device
  • Surgical
  • Diagnostic
  • cardiac
  • Therapeutic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 6931

License Grant
During 2010 we had royalty agreements related to our AtriClip system, which is designed to safely and effectively exclude the left atrial appendage.
License Property
Our AtriClip system is designed to exclude the left atrial appendage by implanting the device during concomitant open surgical procedures from the outside of the heart, avoiding contact with the circulating blood pool while eliminating blood flow between the left atrial appendage and the atria. We believe that our AtriClip system is potentially safer, more effective and easier to use when permanently excluding the left atrial appendage than current products and techniques.
Field of Use
The rights granted apply to medical devices relating to the healthcare industry.

IPSCIO Record ID: 6158

License Grant
The Licensee and the Licensors, two individuals, entered into a worldwide License agreement for  the Invention, including without limitation the entire right, title and interest to the Patent Rights to the  Atrial Septal Defect (ASD) and a Patent Ductus Arteriosus (PDA) Device Percutaneous Catheter Directed Intravascular Occlusion Devices – US Patent 5725552 .  The agreement shall continue in full force and effect for the commercial life of all products covered under this Agreement unless otherwise terminated. Inventors also grant the Licensee the exclusive right, but not the obligation, to use one or all of the inventors, names in its name or trademark for any Products and to use one or all of the inventors’ names in connection with the advertising and marketing of Products.  Intra-cardiac devices are used in various medical procedures
License Property
Atrial septal defect (ASD) is a form of congenital heart defect that enables blood flow between two compartments of the heart called the left and right atria.
Patent ductus arteriosus (PDA) is a congenital disorder in the heart wherein a neonate's ductus arteriosus fails to close after birth.

IPSCIO Record ID: 6456

License Grant
The Licensee entered into a royalty agreement with the Licensor, an individual, the co-inventor of the Lumitip dissector, a blunt dissection tool.
License Property
Wolf Dissector shall mean the articulating, illuminating disposable handpiece designed to perform a dissection or any evolution of such device, including, but not limited to, the integration of such device into the Licensee bi-polar ablation system.

The Lumitipâ„¢ dissector  transfer guide allows the surgeon to dissect tissues from a thorascopic approach.

Field of Use
Field of Use relates to the medical industry.

Licensee is in the surgical and medical instruments industry, specifically developing technologies that provide doctors alternative, more expedient methods to ablate tissue during surgical procedures and treat the left atrial appendage in order to reduce the incidences of stroke.

IPSCIO Record ID: 3394

License Grant
The Licensor granted the Company the exclusive world-wide rights to develop, make and sell the HCMS, a minimally invasive two-balloon esophageal catheter system used to monitor cardiac performance.
License Property
The HCMS will provide the primary measures of cardiac performance and left atrial pressure which are crucial measurements in treating critically ill patients.

5,048,532-Method and Apparatus for Measuring Blood Pressure (S-409)
5,181,517-Method and Apparatus for the Measurement of Atrial Pressure (S-409)

IPSCIO Record ID: 5656

License Grant
Licensor grants to Licensee a worldwide non exclusive non transferable license under Licensed Technology to make, use, have made or sell Licensed Products.
License Property
Licensed Product(s) means external defibrillator(s) for defibrillating the atria of a heart with temporary catheters and/or heart wires for internal defibrillation which is covered in the country of manufacture and/or sale by one or more claims of a patent included in the Licensed Technology.  Licensor owns the exclusive rights to a U.S. Patent No. 5,207,219 and foreign counterparts thereof (hereinafter referred to as (Licensed Technology).
Field of Use
The rights granted apply to the heart.

IPSCIO Record ID: 6937

License Grant
The Licensor granted the Licensee the exclusive world-wide rights to develop, manufacture and distribute the SCMS, a minimally invasive two-balloon esophageal catheter system used to monitor cardiac performance.
License Property
Tangible Property
1. One prototype two-balloon esophogeal catheter.
2. One prototype system control box.
3. One copy of Source Code.
4. One laptop with operational Source Code, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.
5. One Dynamap Blood Pressure Monitor, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.
6. One ECG device compatible with the system, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.

5,048,532 U.S. Patent Method and Apparatus for Measuring Blood Pressure (S-409)

5,181,517 U.S. Continuation in Part Patent Method and Apparatus for the Measurement of Atrial Pressure (S-409)

5,263,485 U.S. Continuation in Part Patent Combination Esophageal Catheter for the Measurement of Atrial Pressure (S-409

6,120,442 U.S. Patent Method and Apparatus for Noninvasive Determination of Cardiac Performance Parameters (R-5421)

5,697,375 U.S. Continuation in Part Patent Method and Apparatus Utilizing Heart Sounds for Determining Pressure Associated with the Left Atrium (S-409)

IPSCIO Record ID: 233454

License Grant
Licensor grants an exclusive, irrevocable, worldwide, perpetual license in, to and under Licensors Intellectual Property and to Licensors rights in the Invention(s), with the right to sublicense, to develop, make, have made, use, import, offer for sale and sell Surgical Products, including any Surgical Products offered by Licensor and accepted by Licensee pursuant to the Distribution Agreement at the time of, or prior to, such termination, in the Territory,
License Property
Products means products, processes, technology and services, along with accessories related to the use thereof.

Surgical Products means Products related to or with applications in the Field of Use.  The Phase 1 surgical products include
• Endocardial probe for use with a diode laser power source (980 nm wavelength) to create endocardial lesions on the heart to treat atrial fibrillation.
• Encircle wand for use with a diode laser power source (980 nm wavelength} to create epicardial lesions through a less invasive point of access to treat atrial fibrillation.
• Universal disposable probe for use with a laser power source to create endocardial and epicardial lesions on the heart to treat atrial fibrillation.
• Diode laser power source ( 980 nm wavelength).
• All other enabling accessories and operating and maintenance manuals related to any of the above.

The Phase 2 products include
• Conduction block indicator for use with the Encircle device and the Universal disposable probe.
• All other enabling accessories and operating and maintenance manuals related to any of the above.

Field of Use
The Field of Use means the surgical treatment of atrial fibrillation and atrial flutter, including, without limitation, minimally invasive surgical treatment of atrial fibrillation and atrial flutter.

IPSCIO Record ID: 26662

License Grant
Licensor grants to Licensee an exclusive license under its Technology rights to (a) develop, make, have made, use, sell and offer for sale or otherwise exploit the Licensed Products, and (b) use and reproduce Software, create Derivatives, and distribute Software to end-users through the normal channels of distribution, in the Field and Territory during the Term. Licensees will have the unrestricted right to develop Licensee Improvements relating to the Licensed Products in the United States for distribution and exploitation of the Licensed Products either in the United States or outside of the United States. Licensee will also have the unrestricted right to develop Licensee Improvements relating to the Licensed Products in any foreign country for distribution and exploitation of the Licensed Products in any other country, including the U.S.
License Property
Patents relate to develop, make and sell the HCMS, a minimally invasive two-balloon esophageal catheter system used to monitor cardiac performance.

TANGIBLE PROPERTY
1.  One prototype two-balloon esophogeal catheter.

2.  One prototype system control box.

3.  One copy of Source Code.

4.  One laptop with operational Source Code, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.

5.  One Dynamap Blood Pressure Monitor, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.

6.  One ECG device compatible with the system, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.

PATENTS
5,048,532
U.S. Patent
Method and Apparatus for Measuring Blood Pressure (S-409)

5,181,517
U.S. Continuation in Part Patent
Method and Apparatus for the Measurement of Atrial Pressure (S-409)

PCT/US
Corresponds to U.S. 5,181,517
Method and Apparatus for the Measurement of Atrial Pressure (S-409)

91/04504

5,263,485
U.S. Continuation in Part Patent
Combination Esophageal Catheter for the Measurement of Atrial Pressure (S-409)

5,398,692
U.S. Continuation in Part Patent
Combination Esophageal Catheter for the Measurement of Atrial Pressure (S-409))

5,551,439
U.S. Continuation in Part Patent
Method of Determining a Mean Pressure from a Source within a Body (S-409)

5,570,671
U.S. Continuation in Part Patent
Method for Positioning Esophageal Catheter for Determining Pressures Associated with the Left Atrium (S-409)

5,697,375
U.S. Continuation in Part Patent
Method and Apparatus Utilizing Heart Sounds for Determining Pressure Associated with the Left Atrium (S-409)

5,921,935
U.S. Divisional Patent
Method and Apparatus for Utilizing Heart Sounds For Determining Pressures Associated with the Left Atrium (S-409)

PCT/US
Corresponds to U.S. ‘671, ‘375, ‘935
Method and Apparatus for Determining Pressures Associated with the Left Atrium (S-409)

96/17617

IPSCIO Record ID: 27406

License Grant
The Company, in its acquisition of technology in 1993 related to its TMR therapy from the University.  Under this agreement, the Company has a worldwide exclusive license to any patents that issue in connection related with cardiac revascularization technology for the treatment of advanced cardiovascular disease and severe angina pain through transmyocardial revascularization, TMR.
License Property
TMR is a treatment aimed at improving blood flow to areas of the heart that were not treated by angioplasty or surgery. A special carbon dioxide (CO2) laser is used to create small channels in the heart muscle, improving blood flow in the heart. TMR is a surgical procedure. The procedure is performed through a small left chest incision or through a midline incision. Frequently, it is performed with coronary artery bypass surgery, but occasionally it is performed independently.
Field of Use
Field of use  Medical Industry primarily used by a heart surgeon.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.